Foresite Capital Management Iv, Llc Insider Trades

Insider Trading History

Track insider trading activity for Foresite Capital Management Iv, Llc. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Kinnate Biopharma
Kinnate Biopharma KNTE
10% owner
Holding Value $0 0 shares
Last Trade
Apr 03, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$1.35M 520,711 shares
$2.59
$2.65
Kinnate Biopharma
Kinnate Biopharma KNTE
10% owner
Holding Value $9.34M 3,525,957 shares
Last Trade
May 08, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$4.98M 1,780,000 shares
$2.80
$2.65
Kinnate Biopharma
Kinnate Biopharma KNTE
10% owner
Holding Value $5.23M 1,975,001 shares
Last Trade
Feb 17, 2023 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$7.46M 1,100,000 shares
$6.78
$2.65
Kinnate Biopharma
Kinnate Biopharma KNTE
10% owner
Holding Value $25.6M 9,671,643 shares
Last Trade
Dec 07, 2020 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$411M 9,171,643 shares
$44.85
$2.65
Kinnate Biopharma
Kinnate Biopharma KNTE
10% owner
Holding Value $2.32M 875,001 shares
Last Trade
Dec 07, 2020 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$22.4M 500,001 shares
$44.85
$2.65
Kinnate Biopharma
Kinnate Biopharma KNTE
10% owner
Holding Value $773k 291,667 shares
Last Trade
Dec 07, 2020 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$7.48M 166,667 shares
$44.85
$2.65
Kinnate Biopharma
Kinnate Biopharma KNTE
10% owner
Holding Value $0 0 shares
Last Trade
Dec 07, 2020 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$2.17M 48,376 shares
$44.85
$2.65
Kinnate Biopharma
Kinnate Biopharma KNTE
10% owner
Holding Value $0 0 shares
Last Trade
Dec 07, 2020 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$4.46M 99,488 shares
$44.85
$2.65
Kinnate Biopharma
Kinnate Biopharma KNTE
10% owner
Holding Value $0 0 shares
Last Trade
Dec 07, 2020 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$836k 18,641 shares
$44.85
$2.65
Kinnate Biopharma
Kinnate Biopharma KNTE
10% owner
Holding Value $994k 375,000 shares
Last Trade
Dec 03, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$14.6M 375,000 shares
$39.03
$2.65
Kinnate Biopharma
Kinnate Biopharma KNTE
10% owner
Holding Value $331k 125,000 shares
Last Trade
Dec 03, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.88M 125,000 shares
$39.03
$2.65
Kinnate Biopharma
Kinnate Biopharma KNTE
10% owner
Holding Value $1.33M 500,000 shares
Last Trade
Dec 03, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$19.5M 500,000 shares
$39.03
$2.65
Kinnate Biopharma
Kinnate Biopharma KNTE
10% owner
Holding Value $0 0 shares
Last Trade
Dec 02, 2020 Sale
No data
No data
$2.65
Kinnate Biopharma
Kinnate Biopharma KNTE
10% owner
Holding Value $0 0 shares
Last Trade
Dec 02, 2020 Sale
No data
No data
$2.65
Kinnate Biopharma
Kinnate Biopharma KNTE
10% owner
Holding Value $0 0 shares
Last Trade
Dec 02, 2020 Sale
No data
No data
$2.65
Aerie Pharmaceuticals
Aerie Pharmaceuticals AERI
10% owner
Holding Value $22.9M 1,501,400 shares
Last Trade
Dec 20, 2019 Purchase (In The Money)Reported as In The Money on SEC Form 4.
$706k 28,900 shares
$24.42
$15.25
Aerie Pharmaceuticals
Aerie Pharmaceuticals AERI
10% owner
Holding Value $0 0 shares
Last Trade
Dec 20, 2019 Sale (In The Money)Reported as In The Money on SEC Form 4.
$7.06k 289 shares
$24.42
$15.25
Aerie Pharmaceuticals
Aerie Pharmaceuticals AERI
10% owner
Holding Value $4.41k 289 shares
Last Trade
Dec 03, 2019 Sale (In The Money)Reported as In The Money on SEC Form 4.
$5.08k 266 shares
$19.08
$15.25
Aerie Pharmaceuticals
Aerie Pharmaceuticals AERI
10% owner
Holding Value $22.5M 1,472,500 shares
Last Trade
Dec 03, 2019 Purchase (In The Money)Reported as In The Money on SEC Form 4.
$508k 26,600 shares
$19.08
$15.25
Aerie Pharmaceuticals
Aerie Pharmaceuticals AERI
10% owner
Holding Value $22M 1,445,900 shares
Last Trade
Nov 26, 2019 Purchase (In The Money)Reported as In The Money on SEC Form 4.
$79.6k 4,400 shares
$18.09
$15.25

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up